Adapting TB services during the COVID-19 pandemic in Mumbai, India

Meneguim, Augusto C; Rebello, Letícia C; Das, Mayank; Ravi, Shilpa; Mathur, T. N.; Mankar, Suchitra; Kharate, Sunita; Tipre, Pranita; Oswal, Vikas; Iyer, Alexander A.; Mansoor, Hend; Kalon, Stobdan; Garone, Daniela; Ferlazzo, Gabriella; Isaakidis, Petros

doi:10.5588/ijtld.20.0537

Cited by 27 publications

(25 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These findings of declines in TB case detection are similar to reports from other health facilities and clinics in Nigeria [24], Brazil [25], China [26] and India [27]. Our study and these clinic reports align with a recent report from WHO showing an overall 21% shortfall in TB case notifications in 84 countries in 2020 compared with 2019 [28].…”

Section: Discussionsupporting

confidence: 91%

Assessing the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Selected Health Facilities in Nairobi, Kenya

Mbithi¹,

Thekkur

Chakaya

et al. 2021

TropicalMed

View full text Add to dashboard Cite

There was concern that the COVID-19 pandemic would adversely affect TB and HIV programme services in Kenya. We set up real-time monthly surveillance of TB and HIV activities in 18 health facilities in Nairobi so that interventions could be implemented to counteract anticipated declining trends. Aggregate data were collected and reported monthly to programme heads during the COVID-19 period (March 2020–February 2021) using EpiCollect5 and compared with monthly data collected during the pre-COVID period (March 2019–February 2020). During the COVID-19 period, there was an overall decrease in people with presumptive pulmonary TB (31.2%), diagnosed and registered with TB (28.0%) and in those tested for HIV (50.5%). Interventions to improve TB case detection and HIV testing were implemented from August 2020 and were associated with improvements in all parameters during the second six months of the COVID-19 period. During the COVID-19 period, there were small increases in TB treatment success (65.0% to 67.0%) and referral of HIV-positive persons to antiretroviral therapy (91.2% to 92.9%): this was more apparent in the second six months after interventions were implemented. Programmatic interventions were associated with improved case detection and treatment outcomes during the COVID-19 period, suggesting that monthly real-time surveillance is useful during unprecedented events.

show abstract

Section: Discussionsupporting

confidence: 91%

Assessing the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Selected Health Facilities in Nairobi, Kenya

Mbithi¹,

Thekkur

Chakaya

et al. 2021

TropicalMed

View full text Add to dashboard Cite

show abstract

“…There are several other suggestions about how TB services could be sustained or improved in the face of the pandemic. These include: better integration and screening of TB and COVID-19 at the health facility and community level; sharing testing algorithms and multiplexing equipment such as GeneXpert platforms within the laboratories; having robust procurement and delivery systems to avoid reagent stock-outs; ensuring effective infection, prevention and control activities within health facilities; having longer 3-month follow-up appointments for patient check-ups and drug collection; providing health information education in health facilities and the community; and mobilizing support networks of TB survivors and TB communities [ 42 , 43 , 44 ]. More use of digital platforms for case finding, drug adherence, management of adverse drug reactions and training have also been recommended as a way of rapidly restoring TB diagnosis, care and prevention services [ 45 ].…”

Section: Discussionmentioning

confidence: 99%

Operational Research to Assess the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Health Facilities in Harare, Zimbabwe

et al. 2021

View full text Add to dashboard Cite

When COVID-19 was declared a pandemic, there was concern that TB and HIV services in Zimbabwe would be severely affected. We set up real-time monthly surveillance of TB and HIV activities in 10 health facilities in Harare to capture trends in TB case detection, TB treatment outcomes and HIV testing and use these data to facilitate corrective action. Aggregate data were collected monthly during the COVID-19 period (March 2020–February 2021) using EpiCollect5 and compared with monthly data extracted for the pre-COVID-19 period (March 2019–February 2020). Monthly reports were sent to program directors. During the COVID-19 period, there was a decrease in persons with presumptive pulmonary TB (40.6%), in patients registered for TB treatment (33.7%) and in individuals tested for HIV (62.8%). The HIV testing decline improved in the second 6 months of the COVID-19 period. However, TB case finding deteriorated further, associated with expiry of diagnostic reagents. During the COVID-19 period, TB treatment success decreased from 80.9 to 69.3%, and referral of HIV-positive persons to antiretroviral therapy decreased from 95.7 to 91.7%. Declining trends in TB and HIV case detection and TB treatment outcomes were not fully redressed despite real-time monthly surveillance. More support is needed to transform this useful information into action.

show abstract

“…O impacto da associação da tuberculose com a COVID-19 nos serviços de saúde e nas atividades de pesquisa já foi claramente destacado em diversos estudos, embora ainda não se saiba o real impacto econômico total. (27)(28)(29)(30)(31)(32)(33)(34)(35) Um estudo recente da Global Tuberculosis Network (5) indicou claramente que a taxa de diagnóstico de tuberculose ativa e latente diminuiu durante a pandemia de COVID-19 em muitos países, e isso pode ter sérias consequências para a incidência e a mortalidade por tuberculose no futuro. Um estudo interessante abordou recentemente aspectos da questão no Brasil.…”

Section: Impacto Nos Serviços De Saúde E Nas Atividades De Pesquisaunclassified

Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?

et al. 2021

View full text Add to dashboard Cite

Em 1º de abril de 2020, a COVID-19 ultrapassou a tuberculose em número de óbitos por dia no mundo. A associação da tuberculose com a COVID-19 apresenta grande potencial de morbidade e mortalidade. Além disso, a pandemia de COVID-19 tem tido um impacto significativo no diagnóstico e tratamento da tuberculose. Neste artigo de revisão, abordamos tuberculose e COVID-19 concomitantes, com particular atenção às diferenças entre Brasil e Europa. Além disso, discutimos as prioridades em atendimento clínico, saúde pública e pesquisa. Descritores: Tuberculose; Infecções por coronavirus; Betacoronavirus; Coronavirus.

show abstract

Adapting TB services during the COVID-19 pandemic in Mumbai, India

Cited by 27 publications

References 0 publications

Assessing the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Selected Health Facilities in Nairobi, Kenya

Assessing the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Selected Health Facilities in Nairobi, Kenya

Operational Research to Assess the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Health Facilities in Harare, Zimbabwe

Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?

Contact Info

Product

Resources

About